Business & Policy NewsMar 17, 2021By DDNews StaffRoche gains GenMarkRoche will acquire the California-based diagnostics company for $1.8 billion
Business & Policy NewsMar 10, 2021By DDNews StaffIn-vitro investmentCELLINK to expand testing offerings with acquisition of MatTek
Business & Policy NewsFeb 26, 2021By Mel J. YeatesThermo Fisher acquires Mesa BiotechThermo Fisher has completed the acquisition of Mesa Biotech and its Accula System PCR testing platform
Business & Policy NewsFeb 04, 2021By DDNews StaffNew growth is on the HorizonHorizon to acquire Viela Bio for $3.05B
Business & Policy NewsJan 26, 2021By Mel J. YeatesJameel Clinic teams up with Sanofi on AI and machine learningThe collaboration will develop and apply deep learning and machine learning for drug discovery
Clinical ResearchJan 26, 2021By DDNews StaffChimerix acquires OncoceuticsMove will expand Chimerix pipeline with late-stage oncology program
Business & Policy NewsJan 16, 2021By Mel J. YeatesThermo Fisher Scientific buys Henogen from NovasepAcquisition will expand Thermo Fisher’s global capacity for cell and gene therapies
Business & Policy NewsJan 07, 2021By DDNews StaffCharles River snags partner Distributed Bio for $83MDistributed Bio adds large-molecule discovery platform to Charles River's repertoire
Business & Policy NewsDec 23, 2020By DDNews StaffServier pays $2 billion for Agios' oncology businessThe deal nets Servier a clinical oncology portfolio and will expand its U.S. footprint
Business & Policy NewsNov 25, 2020By DDNews StaffMerck snaps up OncoImmune for $425MThe acquisition nets Merck a pipeline of oncology programs as well as CD24Fc, OncoImmune's lead candidate for the treatment of COVID-19